196 related articles for article (PubMed ID: 31974144)
1. Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis.
Suppli MP; Bagger JI; Lund A; Demant M; van Hall G; Strandberg C; Kønig MJ; Rigbolt K; Langhoff JL; Wewer Albrechtsen NJ; Holst JJ; Vilsbøll T; Knop FK
Diabetes; 2020 Jun; 69(6):1090-1099. PubMed ID: 31974144
[TBL] [Abstract][Full Text] [Related]
2. Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis.
Winther-Sørensen M; Galsgaard KD; Santos A; Trammell SAJ; Sulek K; Kuhre RE; Pedersen J; Andersen DB; Hassing AS; Dall M; Treebak JT; Gillum MP; Torekov SS; Windeløv JA; Hunt JE; Kjeldsen SAS; Jepsen SL; Vasilopoulou CG; Knop FK; Ørskov C; Werge MP; Bisgaard HC; Eriksen PL; Vilstrup H; Gluud LL; Holst JJ; Wewer Albrechtsen NJ
Mol Metab; 2020 Dec; 42():101080. PubMed ID: 32937194
[TBL] [Abstract][Full Text] [Related]
3. The Liver-α-Cell Axis and Type 2 Diabetes.
Wewer Albrechtsen NJ; Pedersen J; Galsgaard KD; Winther-Sørensen M; Suppli MP; Janah L; Gromada J; Vilstrup H; Knop FK; Holst JJ
Endocr Rev; 2019 Oct; 40(5):1353-1366. PubMed ID: 30920583
[TBL] [Abstract][Full Text] [Related]
4. Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention.
Suppli MP; Høgedal A; Bagger JI; Chabanova E; van Hall G; Forman JL; Christensen MB; Albrechtsen NJW; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2024 Mar; 109(4):955-967. PubMed ID: 37967235
[TBL] [Abstract][Full Text] [Related]
5. Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
Wewer Albrechtsen NJ; Junker AE; Christensen M; Hædersdal S; Wibrand F; Lund AM; Galsgaard KD; Holst JJ; Knop FK; Vilsbøll T
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G91-G96. PubMed ID: 28971838
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.
Wewer Albrechtsen NJ; Færch K; Jensen TM; Witte DR; Pedersen J; Mahendran Y; Jonsson AE; Galsgaard KD; Winther-Sørensen M; Torekov SS; Lauritzen T; Pedersen O; Knop FK; Hansen T; Jørgensen ME; Vistisen D; Holst JJ
Diabetologia; 2018 Mar; 61(3):671-680. PubMed ID: 29305624
[TBL] [Abstract][Full Text] [Related]
7. Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.
Galsgaard KD; Winther-Sørensen M; Ørskov C; Kissow H; Poulsen SS; Vilstrup H; Prehn C; Adamski J; Jepsen SL; Hartmann B; Hunt J; Charron MJ; Pedersen J; Wewer Albrechtsen NJ; Holst JJ
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E93-E103. PubMed ID: 28978545
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a catabolic role of glucagon during an amino acid load.
Charlton MR; Adey DB; Nair KS
J Clin Invest; 1996 Jul; 98(1):90-9. PubMed ID: 8690809
[TBL] [Abstract][Full Text] [Related]
9. Circulating amino acids and pancreatic endocrine function after ingestion of a protein-rich meal in obese subjects.
Schmid R; Schusdziarra V; Schulte-Frohlinde E; Maier V; Classen M
J Clin Endocrinol Metab; 1989 Jun; 68(6):1106-10. PubMed ID: 2656733
[TBL] [Abstract][Full Text] [Related]
10. The Liver-α-Cell Axis in Health and in Disease.
Richter MM; Galsgaard KD; Elmelund E; Knop FK; Suppli MP; Holst JJ; Winther-Sørensen M; Kjeldsen SAS; Wewer Albrechtsen NJ
Diabetes; 2022 Sep; 71(9):1852-1861. PubMed ID: 35657688
[TBL] [Abstract][Full Text] [Related]
11. Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids.
Ohneda A; Parada E; Eisentraut AM; Unger RH
J Clin Invest; 1968 Oct; 47(10):2305-22. PubMed ID: 5676526
[TBL] [Abstract][Full Text] [Related]
12. Glucagon Receptor Signaling and Glucagon Resistance.
Janah L; Kjeldsen S; Galsgaard KD; Winther-Sørensen M; Stojanovska E; Pedersen J; Knop FK; Holst JJ; Wewer Albrechtsen NJ
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284506
[TBL] [Abstract][Full Text] [Related]
13. Role of glucagon in disposal of an amino acid load.
Boden G; Tappy L; Jadali F; Hoeldtke RD; Rezvani I; Owen OE
Am J Physiol; 1990 Aug; 259(2 Pt 1):E225-32. PubMed ID: 1974387
[TBL] [Abstract][Full Text] [Related]
14. Glucagon's effect on liver protein metabolism in vivo.
Kraft G; Coate KC; Winnick JJ; Dardevet D; Donahue EP; Cherrington AD; Williams PE; Moore MC
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E263-E272. PubMed ID: 28536182
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
[TBL] [Abstract][Full Text] [Related]
16. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
[TBL] [Abstract][Full Text] [Related]
17. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.
Roden M; Perseghin G; Petersen KF; Hwang JH; Cline GW; Gerow K; Rothman DL; Shulman GI
J Clin Invest; 1996 Feb; 97(3):642-8. PubMed ID: 8609218
[TBL] [Abstract][Full Text] [Related]
18. Obesity dysregulates fasting-induced changes in glucagon secretion.
Stern JH; Smith GI; Chen S; Unger RH; Klein S; Scherer PE
J Endocrinol; 2019 Nov; 243(2):149-160. PubMed ID: 31454790
[TBL] [Abstract][Full Text] [Related]
19. Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose tolerance.
Marchesini G; Bianchi G; Rossi B; Muggeo M; Bonora E
Int J Obes Relat Metab Disord; 2000 May; 24(5):552-8. PubMed ID: 10849575
[TBL] [Abstract][Full Text] [Related]
20. Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man.
Wise JK; Hendler R; Felig P
J Clin Invest; 1973 Nov; 52(11):2774-82. PubMed ID: 4748510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
